Symbol
APUS on NYSE
Investment type
Equity / Common stock, par value $0.01 per share
Latest Disclosed Shares Owned
4,316,618 shares
Security Ownership %
34%

Apimeds Inc. ownership in Apimeds Pharmaceuticals US, Inc. Common stock, par value $0.01 per share (APUS)

26 Jan 2026 - Apimeds Inc. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,316,618 shares of Apimeds Pharmaceuticals US, Inc. Common stock, par value $0.01 per share (APUS). This represents 34% ownership of the company. In their previous filing dated 19 May 2025, Inscobee Inc. had reported owning 4,387,708 shares, indicating a decrease of +1.6%. .